Home LiteratureArticle Details
PMID: 3922766 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Plasma apolipoprotein B metabolism in familial type III dysbetalipoproteinaemia.

European journal of clinical investigation ·Vol. 15 ·No. 2 ·1985-04-00 ·Pages 100-12

Turner PR, Cortese C, Wootton R, Marenah C, Miller NE, Lewis B

Abstract

Lipoprotein metabolism was studied in eleven patients with Type III hyperlipoproteinaemia, one with normolipidaemic dysbetalipoproteinaemia and eight controls. Apolipoprotein B kinetics in very low density, intermediate density and low density lipoproteins (VLDL, IDL and LDL) was investigated. Fractional catabolic rates (FCRs) of VLDL-apo B and IDL-apo B were lower (P less than 0.005 and P less than 0.001) in the patients: 0.064 +/- 0.018 and 0.059 +/- 0.006 h-1 respectively, (mean +/- SEM), compared with 0.219 +/- 0.035 and 0.243 +/- 0.028 h-1. Synthetic rates (SRs) of IDL-apo B varied widely from 1.5 mg kg-1 day-1 in the subject with normolipidaemic dysbetalipoproteinaemia to 2.8-25.2 mg kg-1 day-1 in Type III. The mean time for conversion of IDL-apo B to LDL-apo B was prolonged, 18.7 h compared with 3.8 h in the controls (P less than 0.001). LDL-apo B pool size and SR were lower in the patients (P less than 0.05 for both). Two patients treated with gemfibrozil showed reduced hyperlipidaemia and decreased SR of VLDL-apo B and IDL-apo B. Dysbetalipoproteinaemia is associated with pronounced impairment of IDL and VLDL-remnant catabolism, lipoprotein levels reflecting an interaction between this defect and SR of these lipoproteins.

MeSH Terms
Adult Aged Apolipoproteins B/blood Female Gemfibrozil Humans Hyperlipoproteinemia Type III/blood,drug therapy Kinetics Lipoproteins/blood Lipoproteins, IDL Lipoproteins, LDL/blood Lipoproteins, VLDL/blood Male Middle Aged Pentanoic Acids/therapeutic use
Chemicals
Apolipoproteins B Lipoproteins Lipoproteins, IDL Lipoproteins, LDL Lipoproteins, VLDL Pentanoic Acids Gemfibrozil
Authors & Affiliations
6 authors, click to expand affiliations / ORCID
Turner P R
Cortese C
Wootton R
Marenah C
Miller N E
Lewis B
Article Info
Journal
European journal of clinical investigation
Abbr.
Eur J Clin Invest
ISSN
0014-2972
Published
1985-04-00
Pages
100-12
Language
English
Region
England
NLM ID
0245331
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com